These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

104 related items for PubMed ID: 1578361

  • 81. Specificity in the factor VIII response to vasopressin infusion in man.
    Prowse CV, Sas G, Gader AM, Cort JH, Cash JD.
    Br J Haematol; 1979 Mar; 41(3):437-47. PubMed ID: 427046
    [Abstract] [Full Text] [Related]

  • 82. Structure-activity relationships of vasopressin analogues on release of factor VIII in dogs.
    Vilhardt H, Barth T.
    J Recept Res; 1991 Mar; 11(1-4):233-7. PubMed ID: 1715919
    [Abstract] [Full Text] [Related]

  • 83. Effect of hypotension induced by sodium nitrocyanoferrate (III) on the release of arginine-vasopressin in the unanaesthetized monkey.
    Fumoux F, Czernichow P, Arnauld E, Du Pont J, Vincent JD.
    J Endocrinol; 1978 Sep; 78(3):449-50. PubMed ID: 101639
    [No Abstract] [Full Text] [Related]

  • 84. Vasopressins and factor VIII release.
    Grant PJ, Davies JA, Prentice CR.
    Lancet; 1985 Jul 27; 2(8448):224. PubMed ID: 2862414
    [No Abstract] [Full Text] [Related]

  • 85.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 86.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 87.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 88. Clotting dispute.
    Morrissey JH.
    Science; 1996 May 24; 272(5265):1085c. PubMed ID: 17792621
    [No Abstract] [Full Text] [Related]

  • 89. Vasopressin antagonist inhibition of clotting factor release in the rhesus monkey (Macaca mulatta).
    Kinter LB, McConnell I, Goodwin BT, Campbell S, Huffman WF, Arthus MF, Lonergan M, Bichet DG.
    J Pharmacol Exp Ther; 1992 May 24; 261(2):462-9. PubMed ID: 1578361
    [Abstract] [Full Text] [Related]

  • 90. 1-Desamino-8-D-arginine vasopressin (DDAVP) in patients with congenital nephrogenic diabetes insipidus.
    Brink HS, Derkx FH, Boomsma F, Brommer EJ, Schalekamp MA.
    Neth J Med; 1993 Aug 24; 43(1-2):5-12. PubMed ID: 8232694
    [Abstract] [Full Text] [Related]

  • 91.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 92. Flushing and haemodynamic responses to vasopressin peptides in the rhesus monkey.
    Brooks DP, Koster PF, Stassen FL, Albrightson CR, Huffman WF, Wasserman MA, Kinter LB.
    Br J Pharmacol; 1988 Jul 24; 94(3):759-64. PubMed ID: 3179611
    [Abstract] [Full Text] [Related]

  • 93. Intravenous DDAVP and factor VIII-von Willebrand factor concentrate for the treatment and prophylaxis of bleedings in patients With von Willebrand disease type 1, 2 and 3.
    Michiels JJ, van Vliet HH, Berneman Z, Gadisseur A, van der Planken M, Schroyens W, van der Velden A, Budde U.
    Clin Appl Thromb Hemost; 2007 Jan 24; 13(1):14-34. PubMed ID: 17164493
    [Abstract] [Full Text] [Related]

  • 94. Vasopressin antagonist inhibition of clotting factor release in the rhesus monkey (Macaca mulatta).
    Kinter LB, McConnell I, Goodwin BT, Campbell S, Huffman WF, Arthus MF, Lonergan M, Bichet DG.
    J Pharmacol Exp Ther; 1992 May 24; 261(2):462-9. PubMed ID: 1578361
    [Abstract] [Full Text] [Related]

  • 95. 1-Desamino-8-D-arginine vasopressin (DDAVP) in patients with congenital nephrogenic diabetes insipidus.
    Brink HS, Derkx FH, Boomsma F, Brommer EJ, Schalekamp MA.
    Neth J Med; 1993 Aug 24; 43(1-2):5-12. PubMed ID: 8232694
    [Abstract] [Full Text] [Related]

  • 96. Hemodynamic and coagulation responses to 1-desamino[8-D-arginine] vasopressin in patients with congenital nephrogenic diabetes insipidus.
    Bichet DG, Razi M, Lonergan M, Arthus MF, Papukna V, Kortas C, Barjon JN.
    N Engl J Med; 1988 Apr 07; 318(14):881-7. PubMed ID: 2965301
    [Abstract] [Full Text] [Related]

  • 97. Flushing and haemodynamic responses to vasopressin peptides in the rhesus monkey.
    Brooks DP, Koster PF, Stassen FL, Albrightson CR, Huffman WF, Wasserman MA, Kinter LB.
    Br J Pharmacol; 1988 Jul 07; 94(3):759-64. PubMed ID: 3179611
    [Abstract] [Full Text] [Related]

  • 98. Response of von Willebrand factor parameters to desmopressin in patients with type 1 and type 2 congenital von Willebrand disease: diagnostic and therapeutic implications.
    Michiels JJ, van de Velde A, van Vliet HH, van der Planken M, Schroyens W, Berneman Z.
    Semin Thromb Hemost; 2002 Apr 07; 28(2):111-32. PubMed ID: 11992235
    [Abstract] [Full Text] [Related]

  • 99. Vasopressin antagonist inhibition of clotting factor release in the rhesus monkey (Macaca mulatta).
    Kinter LB, McConnell I, Goodwin BT, Campbell S, Huffman WF, Arthus MF, Lonergan M, Bichet DG.
    J Pharmacol Exp Ther; 1992 May 07; 261(2):462-9. PubMed ID: 1578361
    [Abstract] [Full Text] [Related]

  • 100. Intravenous DDAVP and factor VIII-von Willebrand factor concentrate for the treatment and prophylaxis of bleedings in patients With von Willebrand disease type 1, 2 and 3.
    Michiels JJ, van Vliet HH, Berneman Z, Gadisseur A, van der Planken M, Schroyens W, van der Velden A, Budde U.
    Clin Appl Thromb Hemost; 2007 Jan 07; 13(1):14-34. PubMed ID: 17164493
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.